Short answer
GoHealth, Inc. (GOCO) filed its Q1 2026 10-Q quarterly report on May 18, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $12M (down 94.6% year over year) with net income of −$37M.
Q1 2026 key financials · XBRL
- Revenue
- $12M
- −94.6% YoY
- Net income
- −$37M
- −743.3% YoY
- Operating margin
- -292.0%
- EPS (diluted)
- −$2.36
- −353.8% YoY
Source: XBRL data from the GoHealth, Inc. (GOCO) Q1 2026 10-Q on SEC EDGAR. USD.
GoHealth, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $11.914M, down 94.6% YoY from $220.972M
- Net loss margin (555.1)% vs (4.4)% YoY
- GoHealth Protect growth offset Medicare pullback; Sales per Submission $621 vs $724
- Adjusted EBITDA $(22.222)M, margin (186.5)% vs 19.0%
- Cash preservation, cost cuts, lender discussions, and potential restructuring amid uncertain liquidity and Medicare headwinds
Risk Factors
- New going-concern risk triggered by projected inability to maintain the liquidity covenant within 12 months
- Debt-default risk from potential acceleration if liquidity covenants or scheduled payments are missed
- Capital-structure risk from uncertain lender discussions involving possible change of control or restructuring
- Operational risk from cost-saving initiatives that may fail to restore covenant compliance
- Collateral enforcement risk because accelerated debt could exceed available liquidity for repayment
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GoHealth, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.